Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-560875
Filing Date
2016-04-28
Accepted
2016-04-28 06:13:36
Documents
3
Effectiveness Date
2016-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A d108961ddefa14a.htm DEFA14A 39650
2 GRAPHIC g108961003.jpg GRAPHIC 2971
3 GRAPHIC g108961g50c52.jpg GRAPHIC 7684
  Complete submission text file 0001193125-16-560875.txt   55922
Mailing Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487
Business Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-00100 | Film No.: 161596987
SIC: 2834 Pharmaceutical Preparations